Transcript Highlights:

• disease management continuum.
• And lastly, there are so many different chronic diseases, diabetes, hypertension, heart disease, where
• While co-pay assistance programs cover many diseases, my experience is with multiple sclerosis, a chronic
• , complex, and expensive disease.
• While pharmacists are integral members of health care teams, providing chronic disease management, offering

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• Chronic weight disease is a serious problem in the United States.
• , diabetes, neurological disorders, chronic respiratory diseases, and digestive disorders.
• Additionally, chronic weight disease extends beyond the need to lose pounds.
• In addition to types of cancers that a person suffering with chronic weight disease may experience, I
• That a person suffering with chronic weight disease may experience.

Summary: The committee first took up SB 1377, a bill on medical exemptions for school immunizations. The author and supporters said the measure was a narrow reform to restore physician discretion and reduce what they described as chilling effects from audits and license discipline; opponents from pediatric, medical, public health, and school groups argued the current system already works, protects against fraudulent exemptions, and should not be weakened. Committee members debated the data, the number of exemptions reviewed or revoked, and the effect of the proposed amendments. The bill was amended in committee, but because there was no quorum it was not formally voted on at that time. The committee then heard SB 995, the Masuma Khan Justice Act, which would create a statewide inspection and compliance framework for large private detention facilities. The author and supporters described severe conditions in immigration detention, including denial of medication, unsafe food and water, and lack of oversight, and the bill was presented as a response to those abuses. The California Hospital Association raised concerns about duplicative regulation and overlapping standards, but said it was continuing to work on a solution. The committee discussed constitutional and jurisdictional issues, and the bill was moved on a do-pass motion to the Committee on Judiciary with a 5-0 vote placed on call. Next, SB 1089 was heard, proposing expanded access through CalPERS and CalRX to GLP-1 medications for chronic weight disease and diabetes prevention. The author and supporters from the American Diabetes Association and medical groups argued the drugs are effective tools to prevent type 2 diabetes, reduce long-term costs, and improve health equity, while the author also shared personal experience with weight loss and medication access barriers. There was no opposition testimony. The bill was moved on a do-pass motion to the Committee on Labor, Public Employment, and Retirement with a 5-0 vote placed on call. Finally, the committee heard SB 1221, dealing with Murphy conservatorships for people found not guilty by reason of insanity or otherwise under criminal-mental health conservatorship. Supporters, including prosecutors and psychiatrists, said the bill addresses a gap created by a court decision and would improve public safety and placement decisions for a small population of high-risk individuals. Opponents from county behavioral health and disability rights groups warned it would turn a civil process into a quasi-criminal one, expand district attorney involvement, and disrupt bed prioritization and least-restrictive-placement principles. The discussion centered on the scope of the bill and its amendments, but no final vote was taken in the portion provided.

Transcript Highlights:

• As mentioned, there is no cure at this point. ...disease.
• And we have about more than 10%, maybe 15% of the U.S. adults are affected by chronic kidney disease.
• I mean, both acute and chronic, but most of it is chronic, which is quite a significant medical problem
• So it's a whole big mix of lots of bad stuff that happens with chronic kidney disease.
• Then it predicts kidney disease.

Summary: The House Committee on Health and Mental Health heard public testimony on House Concurrent Resolution 42, Senate Bill 878, House Resolution 538, and House Resolution 4661. HCR 42 would urge Congress to support programs intended to reduce prescription drug costs for Medicaid and Medicare patients; the sponsor said it would help elderly and low-income residents, while an opponent argued the referenced program can cost more than alternatives like GoodRx or local pharmacy pricing. No votes were taken on HCR 42, and the hearing closed after no one appeared in support, opposition, or for information. Senate Bill 878, a pharmacist practice act bill, drew the most discussion. The sponsor said it would codify pandemic-era flexibilities for pharmacists, including administering certain vaccines, providing medication therapy services, dispensing some medical devices, and allowing over-the-counter access to ivermectin and hydroxychloroquine with warning labels and standardized procedures. Supporters from pharmacy chains and the Missouri Pharmacy Association said the bill improves access, especially in rural areas, and keeps pharmacists working at the top of their training. Opponents raised concerns about vaccine authority shifting from the governor to boards, the safety and efficacy of ivermectin and hydroxychloroquine, and the adequacy of warning labels. The committee heard testimony but did not take a vote. The committee also heard two awareness resolutions. House Resolution 538 would designate May 2026 as ALS Awareness Month and call for support of ALS research and advocacy; members spoke in favor, citing the severity of the disease and the need for early access to communication technology and support services. House Resolution 4661 would encourage screening and public education about chronic kidney disease, especially for high-risk patients such as those with diabetes or hypertension, and would ask the Department of Health and Senior Services to consider public-private education efforts. Both resolutions were presented as nonbinding awareness measures, and no votes were taken before the committee adjourned.

Transcript Highlights:

• diseases and heat stress.
• Disease does not discriminate.
• Although HIV is now a manageable chronic condition, every person diagnosed with the disease must take
• disease.
• disease.

Summary: The committee heard SB 1422, which would restore Medi-Cal access for income-eligible undocumented adults beginning January 1, 2027. Senator Durazo and county, labor, health, immigrant-rights, and provider supporters argued the current enrollment freeze shifts costs to counties and hospitals, worsens preventive care, and increases expensive emergency treatment. No opposition testified. Several senators voiced support but also raised concerns about funding and the need for new revenue sources; the chair said she supported the concept and would continue working on financing, but the bill was not voted on because quorum was lost. The committee also heard SB 1023 on PrEP access, SB 1071 on amending death certificates after a homicide finding, SB 1057 on conviction-history review for CNA and home health aide certification, and SB 1088 on advance care planning and POLST/DNR updates. SB 1023’s author and supporters said requiring pharmacy-benefit coverage for injectable PrEP would reduce administrative barriers and improve access, while health plans opposed it as an improper benefit-design mandate; members sought clarification about how the billing pathway would work. SB 1071 drew strong support from victims’ families, law enforcement, and prosecutors who said death certificates should reflect later legal homicide findings, while coroners opposed it as blurring medical and legal determinations and risking data integrity. SB 1057 was presented as a fair-chance workforce measure to expand caregiving jobs for rehabilitated people with records, with no opposition heard. SB 1088 would modernize POLST/DNR rules, including electronic signatures, out-of-state recognition, and clearer signer authority; supporters backed the changes, while clinical nurse specialists opposed the bill for not including them as authorized signers. After quorum was established, the committee took up SB 869, which would require large chain restaurants to display an added-sugar icon next to beverages exceeding half the daily recommended sugar limit. Senator Weber Pierson and supporters from the American Diabetes Association and American Heart Association framed the bill as a transparency measure to help consumers make informed choices and reduce chronic disease risk. The senator responded to opposition concerns by saying existing nutrition information is often hard to find and that the icon would not unduly crowd menus. The hearing continued with testimony on the bill after quorum was reached, but no final vote is reflected in the transcript excerpt.

Transcript Highlights:

• disease, which Lyme disease has been federally reportable for a long time.
• disease.
• From a budget perspective, this matters because chronic disease related to inadequate nutrition is a
• disease.
• diseases.

Summary: The committee first met in executive session and voted House Bill 2309, Representative Jones’ Oregon Harvesting bill, do pass by a vote of 13 ayes and no nays. The committee then moved to public testimony on House Bill 1881, which would schedule xylazine as a controlled substance. Representative Bill Allen said the bill is intended to address xylazine’s role in fentanyl-related overdoses, improve tracking and enforcement, and preserve legitimate veterinary use through carve-outs. A veterinarian from the University of Missouri testified in support, emphasizing xylazine’s long-standing and safe veterinary use and the need to protect agricultural practice while targeting illicit diversion. No opposition was presented, and testimony on the bill concluded. The committee then heard House Bill 1855, which would add alpha-gal syndrome to Missouri’s reportable conditions and create a reporting/surveillance framework. Sponsor Representative Matthew Overcast said the bill was revised to shift reporting from providers to private labs, create a standalone non-communicable disease reporting section, and support data collection for prevalence, education, and federal funding opportunities. Supporters included a lobbyist for the AlphaGal Alliance, a University of Missouri dermatologist/researcher, Extension staff, cattle industry representatives, and multiple patients and family members who described severe dietary restrictions, anxiety, school and work impacts, and the need for better public awareness and treatment research. Opponents argued the bill’s language would expand DHSS authority too broadly, especially the provision allowing the department to designate and enforce rules for noncommunicable diseases, and suggested narrowing the bill and adding opt-in protections. No vote was taken. Finally, the committee began hearing House Bill 2355, Representative Holly Jones’ “food as medicine” bill. Jones argued that nutrition should be treated as a public health intervention and described medically tailored meals, produce prescriptions, and nutrition counseling as tools that can improve outcomes and reduce costs. In questions, members raised concerns about how the proposal would interact with existing food assistance programs such as SNAP, WIC, school meals, and other federal nutrition benefits, and whether the bill would create a new entitlement or duplicate existing aid. The hearing on HB 2355 was still in progress when the transcript ended.

Transcript Highlights:

• HEART DISEASE, CANCER AND UNINTENTIONAL INJURIES.
• , or risk factors leading to heart disease.
• Nausea is not usually associated with heart disease.
• Many more have the disease but simply don't know it.
• DISEASES AND SAVE LIVES. MR.

Keywords: U.S. House of Representatives Floor Proceedings on Monday, June 9, 2025, 1012, house, all

Transcript Highlights:

• women exams, preventative health care. with prevention and monitoring of complications related to diseases
• diseases.
• We spent very little funding on chronic disease.
• But today, 60% of Americans have chronic diseases and we're spending four point three million dollars
• We're also going to make our doctors focus. more on the causes for patient chronic illnesses, rather

Bills: SJR18, SCR9, SCR13, SB10, SB11, SB19, SB20, SB25, SB62, SB260, SB263, SB293, SB314, SB384, SB412, SB441, SB442, SB494, SB523, SB569, SB616, SB688, SB707, SB766, SB842, SB869, SB890, SB914, SB929, SB971, SB992, SB1066, SB1145, SB1621, SJR36, SJR18, SCR9, SCR13, SB616, SB565, SB384, SB372, SB495, SB842, SB971, SB1066, SB929, SB765, SB523, SB62, SB19, SB18, SB666, SB688, SB707, SB888, SB687, SB706, SB847, SB869, SB890, SB992, SB1145, SB494, SB290, SB766, SB11, SB10, SB13, SB263, SB412, SB20, SB441, SB442, SB1621, SB569, SB314, SB25, SB293, SB914, SB260, SB1248, SB740, SB14, SB1006, SB20, SB25, SB260, SB293, SB314, SB384, SB442, SB494, SB616, SB869, SB890, SB929, SB992, SB1145, SB1621, SR232, SR237, SR242, SB16, SB22

Keywords: capital gains, taxation, constitutional amendment, state revenue, individual investment, Supreme Court, judicial independence, Keep Nine, checks and balances, water rights, treaty compliance, Rio Grande, agriculture, drought, international water, Texas water supply, education, Ten Commandments, public schools, religious display

Transcript Highlights:

• health problems, including type 2 diabetes, heart disease, and hypertension.
• As many of us are also painfully aware of the disease of cancer.
• This is why we... ...asthma, heart disease, and other serious health issues.
• , fetal growth and preterm birth, stroke, heart disease, chronic obstructive pulmonary disease, seizures
• We have completely gone to the other side with chronic pain and trying to control it.

Keywords: 995, all

Summary: The Joint Committee on Public Health held a lengthy hearing to take testimony on a wide range of bills related to environmental health, PFAS, medical device chemicals, food access, lead poisoning, air quality, oral health, and school food additives. Chair Driscoll and Chair Decker emphasized that the hearing was for testimony only, no decisions would be made that day, and that written testimony could still be submitted. They also noted the high volume of speakers and asked witnesses to keep remarks brief. A major portion of the hearing focused on PFAS-related legislation, including bills to restrict PFAS in products and food packaging and to create a PFAS remediation trust fund. Municipal officials and advocates described the high costs of PFAS cleanup, especially for drinking water systems, citing Easton’s multimillion-dollar treatment investments and rate increases. Testimony from legislators and advocates argued that Massachusetts should act despite federal uncertainty, and that the state should stop PFAS at the source rather than leaving municipalities and residents to pay for remediation. The committee also heard strong support for a bill banning DEHP in medical devices, with physicians, nurses, and a bill sponsor saying the chemical can leach from IV bags and tubing and that safer alternatives already exist. The committee also heard testimony on bills to establish statewide food truck permitting, with food truck owners and a senator describing the current system as costly, duplicative, and inconsistent across municipalities. Another set of witnesses supported the “Bean New Deal,” which would expand plant-based food options in public institutions, senior nutrition programs, and WIC, citing health, equity, and cost savings. On lead poisoning, housing advocates and a representative backed bills to expand lead-safe housing requirements to all rental units, arguing the current law contributes to discrimination against families with children and leaves too much pre-1978 housing uncertified. The committee also heard support for an outdoor air pollution bill that would create an advisory committee, identify pollution hotspots, expand monitoring, and set reduction targets, with testimony from environmental justice groups, pediatricians, and legislators describing disproportionate asthma and other health harms in overburdened communities. Later testimony addressed oral health bills to create dental therapists and allow dental hygienists to administer nitrous oxide, with supporters saying the measures would expand access, reduce costs, and help underserved patients. The committee also heard testimony on a bill to prohibit harmful food dyes in competitive school foods, with parents describing behavioral and health concerns tied to synthetic dyes. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• Chronic weight disease is a serious problem in the United States.
• , diabetes, neurological disorders, chronic respiratory diseases, and digestive disorders.
• , diabetes, neurological disorders, chronic respiratory diseases, and digestive disorders.
• In addition, Chronic respiratory diseases and digestive disorders.
• In addition to some of these chronic weight diseases, they can extend when you look at this beyond these

Summary: The committee heard SB 921, which would create a tax credit to help agricultural employers offset overtime premium costs for farmworkers. Senator Grove and supporters, including farmworkers, the California Farm Bureau, and agricultural groups, argued the bill would restore lost hours and take-home pay after California’s agricultural overtime law reduced schedules. Opponents, including the California Federation of Labor Unions and CRLA Foundation, argued the proposal would subsidize employers with taxpayer dollars and undermine the principle that employers should pay overtime themselves. The bill was held in subcommittee until more members arrived. The committee then took up SB 1083, a cleanup bill to the prior year’s school employee misconduct database law. The author and supporters said it would add due process protections for classified school employees, require an administrative law judge review before placement in the database, and improve notice and vetting rules for contractors and non-permanent staff. School employer groups and other opponents warned the bill could slow investigations and weaken child-safety protections. The committee approved the bill 3-0 and sent it to Senate Appropriations. Members also considered SB 1089, which would require CalPERS health plans to cover GLP-1 medications and expand access through CalRX for chronic weight management and related health conditions. The author and supporters, including the American Diabetes Association and medical groups, said the drugs can prevent diabetes and improve health outcomes but remain unaffordable for many. Pharma representatives expressed concerns about the bill as drafted but said they were open to continued discussions. The bill passed 4-0 to Appropriations. The committee also approved the consent calendar 4-0. Later, the committee heard SB 954, which would narrow and add guardrails to last year’s CEQA exemption for advanced manufacturing, including environmental review near disadvantaged communities and labor standards such as prevailing wage and skilled-and-trained workforce requirements. Labor, environmental, and community groups supported the bill as a cleanup of an overly broad exemption, while business and manufacturing groups opposed it, warning it would discourage investment and worsen California’s competitiveness. The bill passed 3-1 to Appropriations. Finally, SB 1299, a fire sprinkler fitter certification bill, was heard and passed 3-0 to Appropriations with support from the sprinkler fitters and building trades and no recorded opposition.

Transcript Highlights:

• diseases and heat stress.
• Disease does not discriminate.
• Although HIV is now a manageable chronic condition, every person diagnosed with the disease must take
• disease.
• disease.

Keywords: 987, senate, all

Transcript Highlights:

• Alex Kahn, California Chronic Care Coalition, in support.
• Obesity is a serious disease for many Californians.
• Obesity is a serious disease for many Californians.
• One, obesity is a complex chronic disease and needs to be covered like one.
• Obesity is costly and complex, and we should treat it as the chronic disease that it is.

Summary: The Assembly Health Committee heard several bills focused on health care access, oversight, and affordability. The first major item was SB 306 by Senator Becker, a prior authorization reform bill. Becker and supporters, including the California Medical Association and California Hospital Association, argued that prior authorization delays care, adds administrative burden, and can lead to serious patient harm. The bill was substantially amended late in the process to have DMHC and CDI identify services and drugs to exempt from prior authorization based on utilization data, with safeguards for fraud, waste, abuse, and patient safety. Health plans and insurers opposed the measure as written, saying prior authorization remains an important utilization-management tool and raising concerns about the 90% threshold, drug inclusion, and how modifications are counted. The committee also heard SB 35 by Senator Umberg, which would let cities or counties inspect unlicensed sober living homes if DHCS does not act promptly on complaints. Supporters said the bill would address weak enforcement and protect residents, while one behavioral health directors group opposed it unless amended. Members generally supported the measure, citing problems with unlicensed facilities and the need for local enforcement backup. The committee then heard SB 62, which would codify California’s updated essential health benefits benchmark if approved by the federal government. Senator Wiener said the package would add hearing aids, durable medical equipment, and infertility treatment including IVF, acknowledging that premiums could rise but arguing the benefits were worth it. Health Access California and other advocates supported the bill, while the California Family Council opposed it. The committee also took up SB 596 by Senator Menjivar, which would tighten the rules for hospitals claiming an on-call list as a defense to nurse staffing ratio penalties. Supporters, including nurses and SEIU, said hospitals have used vague or ineffective on-call practices to avoid accountability and that the bill would improve enforcement and patient safety. Hospital groups opposed it, arguing that staffing is highly dynamic, that hospitals need flexibility to manage acuity and emergencies, and that the bill could increase costs and interfere with collective bargaining arrangements. Finally, the committee heard SB 40 by Senator Wiener, the Insulin Affordability Act, which would cap insulin copays at $35 for a 30-day supply and restrict step therapy unless a plan covers at least one insulin in each drug type. Supporters, including physicians, diabetes advocates, nurses, students, and patient groups, said insulin is life-saving and too often unaffordable, forcing patients to ration or choose between medication and basic needs. There was no formal opposition testimony, though one member questioned why insulin remains so expensive. The committee also began discussion of SB 363, but the transcript cuts off before that bill’s full presentation or any action on the measures. No votes are recorded in the portion provided, and several bills were noted as consent items earlier in the hearing.

Transcript Highlights:

• Because of chronic disease.
• And those chronic diseases, and we made it easy to be sick in America, are linked to poor lifestyle choices
• Sixty percent of us have a chronic disease.
• So I'm just gonna ask you about prevention in chronic disease and what reforms, if confirmed, that you
• people stay healthy longer and avoid chronic disease and the pain and misery and expense that go along

Keywords: Michael Falkender, Deputy Secretary of the Treasury, IRS, taxpayer privacy, nomination process, committee hearing

Summary: The committee convened to discuss critical issues surrounding the nomination of Michael Falkender for the position of Deputy Secretary of the Treasury. This meeting included a series of remarks from committee members who expressed divergent views on Falkender's qualifications and the implications of his appointment. Senator Wyden voiced strong opposition, arguing that Falkender represents harmful policies expected to be perpetuated under the current administration, especially concerning taxpayer privacy and IRS tactics. Meanwhile, other members defended Falkender, noting his extensive experience, including a commitment to transparency in government operations if confirmed.

Transcript Highlights:

• Chronic weight disease is a serious problem in the United States.
• , diabetes, neurological disorders, chronic respiratory diseases, and digestive disorders.
• In addition, Chronic respiratory diseases and digestive disorders.
• In addition to some of these chronic weight diseases, they can extend when you look at this beyond these
• Further, in addition to increasing cancer risk, chronic weight disease is also associated with more than

Keywords: 987, senate, all

Transcript Highlights:

• over $41 billion a year on chronic disease-related costs.
• I'm just asking you to add Fabry disease and Gaucher disease and NPS1 and Pompe disease and the rest
• of the diseases in the bill.
• I also run a Fabry disease clinic, and I am a person living with Fabry disease.
• disease.

Keywords: 995, all

Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on children’s health, tobacco control, newborn screening, pediatric cancer, palliative care, and professional licensure. Early testimony highlighted Senate bills to expand newborn screening for pyruvate dehydrogenase complex deficiency, lysosomal storage disorders, and congenital CMV, with families and clinicians describing severe diagnostic delays, missed treatment windows, and the benefits of early detection. Speakers also supported a bill to improve pediatric cancer research through a dedicated trust fund, and a bill to extend pediatric palliative care services to age 22, with parents and providers emphasizing continuity of care for seriously ill young people. Several witnesses gave personal accounts in support of the newborn screening measures. Families described children who endured years of misdiagnosis before receiving diagnoses such as Gaucher disease, Fabry disease, Pompe disease, Niemann-Pick disease, and CMV, often after irreversible damage had already occurred. Medical and advocacy witnesses said Massachusetts already collects some of the relevant screening data and argued that results should be reported to families, while others urged the committee to add conditions to the state panel because effective treatments already exist. The committee also heard support for a bill to establish a fetal alcohol spectrum disorder program and training for providers. On tobacco and youth health, testimony supported bills to ban internet tobacco sales, strengthen youth protections, and reduce lung cancer deaths through point-of-sale information and quit-line access. A student testified about easily purchasing flavored nicotine products online without meaningful age verification, and public health advocates backed measures to keep tobacco out of children’s environments. The committee also heard testimony on a bill to ensure parents have access to their children’s medical records through age 16, with exceptions for sensitive services already protected by law. The committee additionally took testimony on an optometry licensure bill, where ophthalmologists opposed language they said could broaden scope of practice and allow optometrists to use the title “optometric physician,” while optometry educators and students supported the bill as a modernization measure with no scope expansion. No votes were taken during the hearing; the chair repeatedly reminded speakers of time limits and noted that written testimony could be submitted for additional comments.

Transcript Highlights:

• diseases and heat stress.
• Disease does not discriminate.
• Although HIV is now a manageable chronic condition, every person diagnosed with the disease must take
• disease.
• disease.

Summary: The Senate Committee on Health heard several bills focused on Medi-Cal access, HIV prevention, death certificate amendments, caregiver certification, advance care planning, and sugar-sweetened beverage labeling. SB 1422 by Senator Durazo would restore Medi-Cal access for income-eligible undocumented adults beginning January 1, 2027. The author and many supporters argued the enrollment freeze shifts costs to counties and hospitals, worsens health outcomes, and undermines California’s prior coverage gains. County, labor, health, immigrant-rights, and provider groups testified in support; there was no opposition. Committee members generally expressed support but also raised concerns about funding and the need for new revenue sources. The bill was discussed while the committee lacked quorum, so no vote was taken at that time. The committee also heard SB 1023 on PrEP access, SB 1071 on death certificate amendments after homicide findings, SB 1057 on criminal-history review for CNA and home health aide certification, and SB 1088 on POLST and advance care planning updates. SB 1023 would require insurers that cover injectable PrEP under the medical benefit to also cover it through the pharmacy benefit; supporters said this would reduce administrative barriers and improve access, while health plans and insurers opposed it as an unnecessary mandate that could blur benefit design lines. SB 1071 would allow next of kin to amend a death certificate’s manner of death to homicide after a final court determination; families and law enforcement supported it as a matter of truth and closure, while coroners opposed it as blurring medical and legal findings and potentially distorting public health data. SB 1057 would replace automatic denial with individualized review for certain convictions in CNA and home health aide certification, and SB 1088 would modernize POLST/DNR rules, including electronic signatures, out-of-state recognition, and clarifying who may sign; both drew support, though clinical nurse specialists opposed SB 1088 because they were not included as authorized signers. Several of these bills were heard without quorum, so no votes were taken during the discussion. After quorum was established, the committee heard SB 869 by Senator Weber-Pierce, which would require large chain restaurants to display a clear added-sugar icon next to beverages exceeding 50% of the daily recommended limit. The author and supporters, including the American Diabetes Association and an emergency physician, said consumers need simple, visible information at the point of purchase to better understand health risks tied to sugary drinks. The bill was framed as a public health transparency measure aimed at diabetes, obesity, and other chronic disease prevention. The transcript ends during testimony on SB 869, before any final committee action or vote is shown.

Transcript Highlights:

• Okay, so kratom and 7-OH products are typically taken by people with chronic illness, chronic pain.
• It is nicknamed the suicide disease. I am, in fact, a suicide survivor.
• And I remember that I used this kratom and 7-OH to help with my chronic pain.
• It's more of like a get high versus getting something that's for chronic pain.
• As a person, I have chronic pain.

Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. Members referenced AB 1088, which would be considered later, and said the hearing was intended to clarify the science, medical perspective, and whether stronger safeguards are needed. The first panel featured a toxicology expert, state and local public health officials, an emergency/addiction physician, a medical examiner, and county health representatives. Witnesses from CDPH and Los Angeles County described rising deaths and enforcement actions, including statewide advisories, retailer letters, and product removals from manufacturers, wholesalers, and retailers. Medical testimony emphasized that 7-OH acts much more like an opioid than traditional kratom leaf, can cause dependence, withdrawal, and respiratory depression, and may require naloxone, buprenorphine, or methadone in overdose or withdrawal cases. Local officials said enforcement is difficult because packaging is inconsistent, testing capacity is limited, and counties lack resources and statewide infrastructure; they generally favored a centralized state framework if regulation is pursued. Committee members asked about testing, age restrictions, scheduling, and whether a distinction between kratom and 7-OH could be enforced. Witnesses said forensic labs can potentially test for 7-OH but validated assays are not routine, emergency departments cannot readily distinguish exposures, and local health departments do not have the lab capacity to verify product labels. Several officials warned that a ban or abrupt scheduling could push products into the black market and discourage research, while others argued that current prohibition and enforcement are the most protective approach because legalization or age-limited regulation could create confusion about legality and safety. The second panel included kratom and 7-OH advocates and industry representatives, who argued that natural kratom leaf and concentrated or synthetic 7-OH are different products and should be regulated differently. They supported age-gating, labeling, testing, and packaging rules for kratom leaf while opposing a ban on the botanical. They said 7-OH is used by many adults for pain relief or harm reduction, and that prohibition would drive consumers to illicit markets and worsen harm. Committee members pressed them on whether 7-OH is more potent than kratom, the availability of testing, and whether any safe dose is known. The hearing ended without a vote or formal action, with the chair noting the issue will continue to be considered in future legislation.

Transcript Highlights:

• disease than another CCO, so that CCO that has higher chronic disease will get a little more.
• disease, and they need more health care.
• a chronic disease, they need more health care.
• disease management, and again, are really targeted.
• Home visiting, chronic disease management, and again, are really targeted toward those metrics that were

Keywords: 907, all

Summary: The committee held an informational hearing focused first on Oregon Medicaid coordinated care organization (CCO) finances and rate setting. Oregon Health Authority staff explained how 2025 CCO financial results will inform 2027 capitation rates, including reserve requirements, subcapitation arrangements, and major cost drivers such as behavioral health, pharmacy, rural hospital costs, and dental directed payments. They said the Legislature’s added 2025 funding materially improved CCO margins and that, without it, the program would have been negative overall. Members asked about retained earnings, subcapitation, behavioral health utilization, ABA therapy, and whether outcomes are being evaluated; OHA said rate setting is actuarial and that CCOs, OHA, and other partners all play roles in monitoring efficacy and access. OHA also reviewed House Bill 4039 changes intended to increase transparency and give CCOs earlier access to rate information and reconciliation exhibits. CCO representatives then testified that the system is under significant financial pressure and that behavioral health state-directed payments, benefit changes, and federal uncertainty from H.R. 1 are reducing flexibility. CareOregon said it has lost more than $500 million over the last couple of years and is now making provider terminations and other network changes to align spending with available funding, while emphasizing that CCOs must make hard decisions about which services and providers can be sustained. Eastern Oregon CCO said rural and frontier factors, cost-based hospitals, air ambulance needs, and statewide efficiency adjustments are not fully reflected in rates, and that dental funding is especially strained. Trillium similarly warned that state-directed payments and benefit expansion pressures are constraining the global budget model and that H.R. 1 could worsen acuity and volatility. Members pressed the witnesses on who is responsible for evaluating treatment effectiveness, especially for ABA and psychotherapy, and on how utilization limits and reimbursement changes are being used to control costs. The committee then shifted to an overview of the Affordable Care Act and Oregon’s commercial insurance market. Department of Consumer and Business Services staff explained actuarial value, metal tiers, premium tax credits, medical loss ratio rules, and the main drivers of premium rates: cost trend, utilization trend, and administrative costs. They said mandates have likely added only a limited amount to premiums over the past decade, though the exact effect is difficult to isolate, and they gave examples of how high-cost, low-volume services versus broad, high-utilization services can affect rates differently. Staff also noted that Providence Health Plan and PacificSource Health Plans are withdrawing from the individual market, though consumers should still have at least three insurer options in every county and may have four in many counties. The division said it is in the middle of reviewing proposed 2027 rates and will continue its public rate review process, including hearings and written comment.

Transcript Highlights:

• prevention, especially chronic disease, and public health services.
• We'll move to page 63 for the Cancer and Chronic Disease Control and Prevention Corps.
• This core reflects programmatic areas that work on prevention of cancer and chronic diseases such as
• A couple of questions here in this general section talking about chronic diseases and then the communicable
• “On the chronic disease prevention side, there is limited federal dollars that come into the state, and

Keywords: 959, house, all

Summary: The committee heard the Department of Health and Senior Services’ FY 2027 budget presentation from Director Sarah Wilson and budget director Maddie Starns, followed by testimony from division directors. Wilson framed the budget as one shaped by fiscal pressure, federal funding dependence, and the need to preserve core public health and senior services while reducing spending. She emphasized the department’s role in outbreak response, newborn screening, cannabis regulation, senior services, licensure, and administration, and said priorities include workforce capacity, data modernization, and protecting essential functions. Members repeatedly praised the department for being responsive and for working to identify savings and reallocate funds carefully. A major focus was the shift in substance use disorder funding. The department explained that the governor’s budget reduces DHSS’s direct SUD grant authority from the Health Reinvestment Fund while proposing transfer authority to the Department of Mental Health and the Department of Corrections for related initiatives. Several members pressed for clarity on whether this represented real cuts or a transfer of the same adult-use marijuana revenue, and staff said some line items were reductions while others would be picked up in other departments’ budgets. The committee also discussed tobacco prevention and cessation reductions, local public health agency support, and the department’s use of federal versus general revenue, with members urging the department to spend federal and other funds before GR whenever possible. Members asked detailed questions about lapses, vacant FTEs, donated funds, loan repayment defaults, rural health programs, CHIP vaccine costs, nutrition services, and the J-1 visa waiver program. DHSS said many lapses were due to federal timing, pandemic-related funds, or program realignment, and that some excess authority was being reduced to better match actual spending. The department reported low default rates in its loan repayment programs and noted that Missouri’s J-1 waiver recommendations are capped federally at 30. There were also questions about local health department incentive payments, minority health activities, and the extended women’s health program, which the governor proposed transferring out of DHSS. The committee also reviewed community and public health programs including communicable disease control, environmental health, maternal and infant mortality review, vital records, and COVID/ARPA cleanup reductions. DHSS said the fetal and infant mortality review program is now operating statewide, though some members raised concerns about a pause during the transition from local NGOs to the new statewide model. The hearing concluded with the state public health laboratory budget, where staff explained funding needs for newborn screening, cannabis reference testing, safe drinking water testing, and courier services, and said some authority increases were needed to match growing program activity.

Transcript Highlights:

• prevention, especially chronic disease, and public health services.
• We’ll move to page 63 for the Cancer and Chronic Disease Control and Prevention core.
• This core reflects programmatic areas that work on prevention of cancer and chronic diseases such as
• A couple of questions here on these, in this general section talking about chronic diseases and then
• And the chronic disease prevention side, there is limited federal dollars that come into the state.

Summary: The committee heard the Missouri Department of Health and Senior Services present its FY 2027 budget request, with Director Sarah Wilson and budget staff describing the department’s mission, major divisions, and the impact of federal funding shifts, especially the FMAP change that will shift costs to general revenue. Wilson emphasized prevention, public health infrastructure, workforce capacity, and data modernization, while several members praised the department’s responsiveness and cost-cutting efforts. The discussion repeatedly focused on lapses, excess authority, and the department’s stated practice of spending federal and other funds before general revenue where possible. Members asked detailed questions about local public health agency support, nutrition programs, rural health and primary care, newborn screening, the state public health lab, and the department’s use of flexibility and reallocations. There was extended discussion of substance use disorder funding: the department explained that some funding is being reduced in its own budget because transfer authority is being added for the Department of Mental Health and the Department of Corrections, while some other SUD-related lines are actual reductions. Members also questioned tobacco prevention and cessation cuts, maternal and infant health programs, fetal infant mortality review, and minority health initiatives, with staff explaining program purposes and noting that some reductions were tied to excess authority or to moving programs to other departments. The committee also reviewed specific operational items such as the Health Initiatives Fund transfer, debt offset escrow for loan repayment defaults, donated funds authority, emergency preparedness, environmental health, health informatics, HIV/STI/hepatitis services, local public health incentives, and the COVID/ARPA authority reductions. Several members requested follow-up information on vacancies, lapse trends, grant spending plans, and program details. No final vote or formal action was taken in the portion provided; the chair recessed briefly and the hearing continued with additional budget testimony.

Transcript Highlights:

• I work with patients managing chronic and complex diseases that require consistent, carefully managed
• Schools should be safe havens, not sources of chronic disease.
• Let's give our children the foundation that should be a safe haven, not sources of chronic disease.
• Kathleen Galjani, on behalf of End Chronic Disease, in support. Thank you.
• Kathleen Galjani, on behalf of End Chronic Disease, in support. Thank you. Thank you.

Summary: The committee heard several health-related bills. AB 1825 by Krell would clarify California’s offenders with mental health disorders program by tightening the standard for determining “substantial danger of physical harm,” improving exit planning, and expanding Medi-Cal access for people released after a successful challenge. Supporters, including psychiatrists, prosecutors, and medical groups, said the bill would close gaps in care and protect public safety; county behavioral health directors and Disability Rights California registered concerns. AB 1696 by Stephanie would state that nurse midwives do not need physician supervision when providing care within their existing scope, including EMTALA-related evaluation in labor and delivery settings. Nurse midwives and nursing groups supported the bill, while emergency physicians opposed it unless amended, arguing emergency department screening should remain under physician supervision; the author said she would keep working on the issue. AB 1949 by Lee would make acupuncture a separate Medi-Cal benefit and allow up to 24 visits per year. The author and supporters from acupuncture, health access, and integrative medicine groups said the current monthly cap is too restrictive and that acupuncture is an effective, cost-saving alternative for pain management and other conditions. There was no opposition. AB 2330 by Patterson would create a distinct regulatory category for cold spas, with standards for construction, operation, and disinfection. Fitness and wellness groups supported the bill, environmental health administrators had no formal position but thanked the author for amendments, and a committee member raised concerns about local officials interpreting the bill to require separate enclosures from saunas; the author said she would continue working on the language. AB 2000 by Aguirre-Curry would limit mid-year changes to prescription drug formularies and add notice, exceptions, reporting, and enforcement provisions. Family physicians, chronic care advocates, nurses, pharmacists, and patient groups supported the bill, citing non-medical switching and treatment disruptions; health plans and insurers opposed it, warning of higher costs, reduced flexibility, and premium increases. AB 1929 by Ortega would require health plans to disclose investments, including in private prisons and immigrant detention centers. Supporters framed it as a transparency measure tied to patient premiums and public values, while opponents argued the bill was duplicative, burdensome, and potentially harmful to investment confidentiality. AB 2746 by Schiavo would classify medical credit card debt as medical debt so it would not appear on credit reports. Consumer advocates and legal aid groups supported the bill, describing abusive marketing and housing harms; banks, debt collectors, and industry groups opposed it as unworkable and privacy-invasive. The committee took roll on AB 2746 and passed it on a due pass motion to Banking and Finance, with several members voting aye and a few no votes recorded.